Show simple item record

dc.contributor.authorKemp, A.
dc.contributor.authorPreen, D.
dc.contributor.authorGlover, J.
dc.contributor.authorSemmens, James
dc.contributor.authorRoughead, E.
dc.date.accessioned2017-01-30T15:15:57Z
dc.date.available2017-01-30T15:15:57Z
dc.date.created2015-03-04T01:07:23Z
dc.date.issued2011
dc.identifier.citationKemp, A. and Preen, D. and Glover, J. and Semmens, J. and Roughead, E. 2011. How much do we spend on prescription medicines?: Out-of-pocket costs for patients in Australia and other OECD countries. Australian Health Review. 35 (3): pp. 341-349.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/44723
dc.identifier.doi10.1071/AH10906
dc.description.abstract

Objectives: To determine changes in out-of-pocket expenditure on prescription medicines for Australian patients, and how patient expenditure compares with other Organisation for Economic Co-operation and Development (OECD) countries. Methods: We examined out-of-pocket expenditure on prescription medicines by patients in Australia between 1970 and 2007, and between Australia and 15 other OECD countries (Canada, Czech Republic, Denmark, Finland, France, Germany, Japan, Republic of Korea (South Korea), Luxembourg, Poland, Slovak Republic, Spain, Sweden, Switzerland and the United States) in 2005. Findings: Spending on publicly subsidised medicines by Australian patients increased from $16 per person in 1971 to $62 in 2007. Patient expenditure on all prescription medicines had risen to $134 per person in 2007. Out-of-pocket expenditure for Australian patients ranked 4th of 14 OCED countries with universal pharmaceutical subsidies. Australian patients pay 28% of national pharmaceutical expenditure; more than patients in South Korea (27%), Slovak Republic (26%), Sweden (22%), France, Luxembourg, Japan and Switzerland (17%), Germany (15%), Czech Republic (11%) and Spain (6%), but less than patients in Finland (36%), Denmark (33%) and Poland (34%). Conclusions: Compared to other OECD countries, Australian out-of-pocket costs are now in the mid to upper range. Further increases have the potential to significantly affect access to care.

dc.publisherCSIRO Publishing
dc.titleHow much do we spend on prescription medicines?: Out-of-pocket costs for patients in Australia and other OECD countries
dc.typeJournal Article
dcterms.source.volume35
dcterms.source.startPage341
dcterms.source.endPage349
dcterms.source.issn0156-5788
dcterms.source.titleAustralian Health Review
curtin.note

This open access article is distributed under the Creative Commons license http://creativecommons.org/licenses/by-nc-nd/4.0/deed.en_US

curtin.departmentCentre for Population Health Research
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record